Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines. Background: Although in use for almost 30 years, the clinical value of CEA as the ...
A novel intelligent biosensing platform consisting of quantum dots luminescence and biochip with machine vision algorithm is proposed for point-of-care carcinoembryonic antigen (CEA) protein ...
ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska Over a 1-year period, the mean ...
Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results